Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arrhythmia and hypertrophic cardiomyopathy.

C F Shakespeare1, P J Keeling, A K Slade

  • 1Department of Cardiological Sciences, St. George's Hospital, Medical School, London, England.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 1, 1992
PubMed
Summary

Atrial fibrillation is common in hypertrophic cardiomyopathy, worsening symptoms. Arrhythmias and autonomic dysfunction can lead to sudden cardiac death in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiomes of microscopic marine invertebrates do not reveal signatures of phylosymbiosis.

Nature microbiology·2022
Same author

Multigene phylogenetics of euglenids based on single-cell transcriptomics of diverse phagotrophs.

Molecular phylogenetics and evolution·2021
Same author

Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.

The British journal of dermatology·2018
Same author

Microsporidia-Emergent Pathogens in the Global Food Chain (Trends in Parasitology 32, 336-348; April 2, 2016).

Trends in parasitology·2016
Same author

Microsporidia - Emergent Pathogens in the Global Food Chain.

Trends in parasitology·2016
Same author

Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.

European journal of medical genetics·2015

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Hypertrophic Cardiomyopathy

Background:

  • Atrial fibrillation is the most frequent arrhythmia in hypertrophic cardiomyopathy (HCM).
  • This arrhythmia is linked to rapid symptom worsening in HCM patients.
  • Non-sustained ventricular tachycardia (NSVT) affects 20% of HCM patients and predicts sudden death.

Purpose of the Study:

  • To review the role of arrhythmias in hypertrophic cardiomyopathy.
  • To discuss the mechanisms of sudden cardiac death in HCM.
  • To outline current therapeutic strategies for arrhythmias in HCM.

Main Methods:

  • Literature review of studies on arrhythmias in hypertrophic cardiomyopathy.
  • Analysis of the relationship between arrhythmias and sudden cardiac death.
  • Discussion of pharmacological management of atrial fibrillation and ventricular arrhythmias.

Main Results:

  • Atrial fibrillation is a common and serious complication in HCM.
  • Non-sustained ventricular tachycardia is a significant predictor of sudden cardiac death in adults with HCM.
  • The proposed mechanism of sudden death involves initiating factors like arrhythmia and autonomic dysfunction, leading to hemodynamic instability and myocardial ischemia.

Conclusions:

  • Arrhythmias, particularly atrial fibrillation and ventricular tachycardia, are critical concerns in HCM management.
  • Understanding the mechanisms of sudden death is crucial for risk stratification and prevention.
  • Appropriate pharmacological interventions are essential for managing arrhythmias and reducing mortality in HCM.

Related Experiment Videos